» Articles » PMID: 36976483

Sex Differences in Glycolipidic Disorders After Exposure to Maternal Hyperglycemia During Early Development

Overview
Publisher Springer
Specialty Endocrinology
Date 2023 Mar 28
PMID 36976483
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this review was to summarize sex differences in glycolipid metabolic phenotypes of human and animal models after exposure to maternal hyperglycemia and overview the underlying mechanisms, providing a new perspective on the maternal hyperglycemia-triggered risk of glycolipidic disorders in offspring.

Methods: A comprehensive literature search within PubMed was performed. Selected publications related to studies on offspring exposed to maternal hyperglycemia investigating the sex differences of glycolipid metabolism were reviewed.

Results: Maternal hyperglycemia increases the risk of glycolipid metabolic disorders in offspring, such as obesity, glucose intolerance and diabetes. Whether with or without intervention, metabolic phenotypes have been shown to exhibit sex differences between male and female offspring in response to maternal hyperglycemia, which may be related to gonadal hormones, organic intrinsic differences, placenta, and epigenetic modifications.

Conclusion: Sex may play a role in the different incidences and pathogenesis of abnormal glycolipid metabolism. More studies investigating both sexes are needed to understand how and why environmental conditions in early life affect long-term health between male and female individuals.

Citing Articles

Gestational diabetes induces autistic-like behaviors in offspring by disrupting the GABAergic system.

Liu X, Huang T, Zhang S, Huang Y, Mo J, Yan Y Front Neurosci. 2025; 19:1538115.

PMID: 40012680 PMC: 11861160. DOI: 10.3389/fnins.2025.1538115.

References
1.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021; 183:109119. PMC: 11057359. DOI: 10.1016/j.diabres.2021.109119. View

2.
Lowe Jr W, Scholtens D, Kuang A, Linder B, Lawrence J, Lebenthal Y . Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes Mellitus and Childhood Glucose Metabolism. Diabetes Care. 2019; 42(3):372-380. PMC: 6385693. DOI: 10.2337/dc18-1646. View

3.
Boerschmann H, Pfluger M, Henneberger L, Ziegler A, Hummel S . Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus. Diabetes Care. 2010; 33(8):1845-9. PMC: 2909075. DOI: 10.2337/dc10-0139. View

4.
Vaarasmaki M, Pouta A, Elliot P, Tapanainen P, Sovio U, Ruokonen A . Adolescent manifestations of metabolic syndrome among children born to women with gestational diabetes in a general-population birth cohort. Am J Epidemiol. 2009; 169(10):1209-15. DOI: 10.1093/aje/kwp020. View

5.
Ding G, Wang F, Shu J, Tian S, Jiang Y, Zhang D . Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes. 2012; 61(5):1133-42. PMC: 3331740. DOI: 10.2337/db11-1314. View